Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

InfuSystem Holdings (INFU) Cost of Revenue (2016 - 2025)

Historic Cost of Revenue for InfuSystem Holdings (INFU) over the last 17 years, with Q3 2025 value amounting to $15.7 million.

  • InfuSystem Holdings' Cost of Revenue fell 372.96% to $15.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $63.0 million, marking a year-over-year decrease of 142.28%. This contributed to the annual value of $64.5 million for FY2024, which is 284.32% up from last year.
  • According to the latest figures from Q3 2025, InfuSystem Holdings' Cost of Revenue is $15.7 million, which was down 372.96% from $16.1 million recorded in Q2 2025.
  • Over the past 5 years, InfuSystem Holdings' Cost of Revenue peaked at $17.0 million during Q2 2024, and registered a low of $9.8 million during Q2 2021.
  • Over the past 5 years, InfuSystem Holdings' median Cost of Revenue value was $15.4 million (recorded in 2023), while the average stood at $14.1 million.
  • Per our database at Business Quant, InfuSystem Holdings' Cost of Revenue surged by 4731.46% in 2023 and then plummeted by 529.65% in 2025.
  • InfuSystem Holdings' Cost of Revenue (Quarter) stood at $12.9 million in 2021, then rose by 14.69% to $14.8 million in 2022, then increased by 2.05% to $15.1 million in 2023, then rose by 3.8% to $15.6 million in 2024, then increased by 0.23% to $15.7 million in 2025.
  • Its Cost of Revenue was $15.7 million in Q3 2025, compared to $16.1 million in Q2 2025 and $15.5 million in Q1 2025.